Cargando…
Disease progression patterns of bevacizumab responders with recurrent malignant gliomas
Tumor progression in patients with recurrent malignant glioma who respond to bevacizumab (BEV) is difficult to assess. The current study reviewed the clinical and radiological results of patients following a BEV-based chemotherapy regimen, and evaluated disease progression patterns in patients who r...
Autores principales: | Kim, Ju-Hwi, Jung, Tae-Young, Hwang, Eu Chang, Jung, Sung-Hoon, Jung, Shin, Kim, In-Young, Jang, Woo-Youl, Moon, Kyung-Sub, Lee, Kyung-Hwa, Kim, Seul-Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588053/ https://www.ncbi.nlm.nih.gov/pubmed/28927109 http://dx.doi.org/10.3892/ol.2017.6630 |
Ejemplares similares
-
Bevacizumab-refractory radiation necrosis with pathologic transformation of benign meningioma following adjuvant gamma knife radiosurgery: A rare case report
por: Kim, You-Sub, et al.
Publicado: (2020) -
Predictive factors for surgical outcome in anterior clinoidal meningiomas: Analysis of 59 consecutive surgically treated cases
por: Kim, Ju-Hwi, et al.
Publicado: (2017) -
Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases
por: Kim, Jo-Heon, et al.
Publicado: (2019) -
Role of Craniofacial Resection for Malignant Tumors Involving the Anterior Skull Base: Surgical Experience in a Single Institution
por: Kim, You-Sub, et al.
Publicado: (2015) -
Ependymomas: Prognostic Factors and Outcome Analysis in a Retrospective Series of 33 Patients
por: Chai, Yong-Hyun, et al.
Publicado: (2017)